Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2007
11/13/2007CA2384322C Polyalkoxylated superamides optionally functionalised, use as emulsifiers
11/08/2007WO2007127867A2 Chromium complexes
11/08/2007WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007WO2007074386B1 A novel process for synthesis of itopride and it’s novel intermediate-n-(4-hydroxybenzyl)-3,4-dimethoxybenzamide
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/08/2007CA2650480A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/07/2007EP1850667A2 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100347151C Novel aminobenzoephenones
11/06/2007US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation
11/01/2007US20070254958 by preventing the formation of insoluble beta-amyloid and arresting the production of beta-amyloid; e.g. 3-{2-[(5-aminopentyl)amino]-2-oxoethoxy}-5-({[(1R)-1-(4-fluorophenyl)ethyl]amino}carbonyl)phenyl phenylmethanesulfonate
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
10/2007
10/31/2007EP1848705A2 Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2007EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists
10/31/2007EP1644319A4 Novel halo-substituted active methylene compounds
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
10/31/2007EP1218337B1 Synthesis of 3,5,7|-1h-imidazo 1,5-a|imidazol-2(3h)-one compounds
10/31/2007CN101062023A Selective androgen receptor modulators and methods of use thereof
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007CA2171218C Metallospheres and superclusters
10/25/2007WO2007120083A1 The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007US20070249865 Process for Preparation of 4-Fluoro-Alpha-[2-Methyl-1-Oxopropyl]-Gamma-Oxo-N-Beta- Diphenylbenzene Butane Amide
10/25/2007US20070249864 Process for Producing (Z)-1-Phenyl-1-Diethylaminocarbonyl-2-Hydroxymethylcyclopropane
10/25/2007US20070249847 Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/24/2007EP1846385A2 An exo-selective synthesis of himbacine analogs
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
10/24/2007EP1846365A1 Diamine calcium channel blockers
10/24/2007EP1846364A1 New potent and selective ligands of cannabinoid receptors
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007CN101058549A 4-methoxy-1,3-phenyl disubstituted amide derivative
10/24/2007CN101058543A Process for producing amine derivatives
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/23/2007US7285600 Nitrile oxide precursor compound for use as irreversible cross-linking agent in polymers
10/23/2007CA2478971C Androstenones
10/23/2007CA2449679C Androstenones
10/18/2007WO2007117176A1 Para-ethoxyaniline derivatives increasing the antiknock rating of hydrocarbon fuels and compositions based thereon
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007US20070244342 Process for Preparing Solid Particles of Phenolic Antioxidants
10/18/2007US20070244198 Carboxylic Derivatives
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007DE102006017681A1 Verfahren zur Herstellung von 8-Aryl-Octanoylderivaten Process for the preparation of 8-aryl-Octanoylderivaten
10/18/2007CA2648074A1 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
10/17/2007EP1845081A1 Amide compound
10/17/2007EP1844003A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007CN101054350A Method for extracting coronatine
10/17/2007CN101054345A Novel bensophenone derivatives or salts thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053830A Catalyst for synthesis salicylamide and its preparation method and application
10/16/2007US7282608 Inhibitors of histone deacetylase
10/11/2007WO2007115269A2 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007WO2007114855A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/11/2007US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring
10/11/2007DE102006016998A1 Tetrahydronaphtol-Derivate und deren Verwendung Tetrahydronaphtol derivatives and their use
10/11/2007CA2648121A1 Preparation of chiral amides and amines
10/11/2007CA2648003A1 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007CA2629321A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/10/2007EP1841728A1 Compounds for treating urinary incontinence
10/10/2007CN101050193A Nitric ester derivatives, its medicinal composition and their medicinal use
10/10/2007CN101049296A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
10/09/2007US7279596 Stable crystals of substituted phenylpropionic acid derivative and process for producing the same
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007CA2252084C Cytoprotective compounds
10/04/2007WO2007074386A3 A novel process for synthesis of itopride and it’s novel intermediate-n-(4-hydroxybenzyl)-3,4-dimethoxybenzamide
10/04/2007WO2007062308A3 Homo- and heterocyclic compounds suitable as cetp inhibitors
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/03/2007EP1838664A1 Manufacture process of n-substituted salicylamides
10/03/2007EP1838278A1 2-c-substituted propane-1,3-dicarbonyl compounds and their use in neutralising malodour
10/03/2007EP1080065B1 A method of permanent fluorescent assay
10/03/2007CN101048369A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
10/03/2007CN101045697A Clausena lansium stone extraction and preparation method thereof
10/03/2007CN101045695A Hydro-reduction method for preparing quinolone intermediate
10/03/2007CN100340543C Cyfluthrin hapten compound, its synthesis method and use
10/03/2007CN100340541C Process for preparation of alpha-hydroxycarboxylic acid amides
10/02/2007US7276534 Carbon-substituted diketopiperazine delivery systems
09/2007
09/27/2007US20070225374 Hydroxypropyl Amides for the Treatment of Alzheimer's Disease
09/27/2007US20070225229 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
09/27/2007DE102006013914A1 Neue 7,12-Dihydro-7,12-dioxo-benz[a]anthracene, deren Herstellung und deren Verwendung als Arzneimittel New 7,12-dihydro-7,12-dioxo-benz [a] anthracene, their preparation and their use as medicaments
09/27/2007CA2637630A1 Process for producing lactamide compounds, new lactamide compounds and formulations containing lactamide compounds
09/26/2007EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
09/26/2007EP1836155A2 Processes for the preparation of aminoethoxybenzyl alcohols
09/26/2007EP1836002A2 Process for the production of strongly adherent coatings
09/26/2007CN101041629A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
09/26/2007CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/25/2007US7273952 Substituted C-cyclohexylmethylamine derivatives
09/25/2007US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007CA2415551C Aniline derivatives
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 157